Please login to the form below

Not currently logged in
Email:
Password:

New Accounts, April, 2009 - PR & Med Ed

New pharmaceutical account wins notified to us by the winning agency for the period February 2009 and March 2009 inclusive:

New pharmaceutical account wins notified to us by the winning agency for the period February 2009 and March 2009 inclusive:

 

CLIENT

PRODUCT

THERAPEUTIC AREA

WINNING AGENCY

AstraZeneca RECENTIN Recurrent glioblastoma multiforme and colorectal cancer IMC Medical Communication
AstraZeneca  ZD4054 Prostate cancer IMC Medical Communication
Celgene Vidaza Haematology Succinct Healthcare Communications
EMD Serono
n/a
Infertility Medaxial
Genzyme Mozobil Oncology Medaxial
Genzyme Thyrogen endocrinology / oncology
Medaxial
Lifeblood: The Thrombosis Charity
National Thrombosis Awareness Week
Corporate Athena
Napp Pharmaceuticals
Targinact Pain Flutter & Wow
Novartis
Exelon patch
Neuroscience
Just::
Novartis global
Stalevo
Neuroscience
Just::
Novartis Oncology International
Zometa
Oncology
PraeMedica
Sanofi-aventis/Bristol-Myers Squibb
n/a
Cardiovascular
Medaxial
SPD Development Company
Clearblue digital pregnancy test
Women's health
IMC Medical Communications
Wyeth ReFacto Haemophilia ROAD 

  

Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may not be involved with some of the products listed in other ways, or in domestic, overseas or international markets.

To submit an entry for New Accounts, email new_accounts@pmlive.com

12th May 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics